Table 2 Disease modeling using 3D human brain organoids and challenges.
From: Human 3D brain organoids: steering the demolecularization of brain and neurological diseases
Neurological disease | Challenge | Brain region-specific organoids | Growth factors/ECM used | Cellular phenotype/phenomenon | Reference |
|---|---|---|---|---|---|
Microcephaly-related disease conditions | |||||
Microcephaly | Mouse models do not mimic the severity of Microcephaly because of smaller brain and limited expansion | Cerebral organoids | Y-27632, N2 supplement, Heparin, Matrigel, B27 supplement without vitamin A, Insulin | Progenitor cells with decreased radial glial cells show premature neural differentiation | [9] |
Microcephaly patients with Aspm mutations possess extremely reduced brain size, which is quite difficult to mimic in animal models | Cortical organoids | endo-IWR1, LDN-193189, SB431542, heparin, BDNF, GDNF, cAMP, matrigel | Patient-derived cortical organoids displayed proliferation deficient progenitors, less mature neurons and abnormal cortical lamination, neuronal dysfunction | [37] | |
Lissencephaly (Miller Dieker Syndrome) | Absence of outer radial glial cells in developing rodent cortex leads to milder phenotypes in Pafah1b1+/− mice as compared to human patients | Cerebral organoids | Y-27632, WNT inhibitor, TGF-β inhibitor, FBS, Matrigel and heparin | Defective cell migration, massive apoptosis of founder neuroepithelial stem cells, Defective mitosis in outer radial glia | [146] |
Neurodevelopmental disorders | |||||
Bipolar disorder | Mechanistic understanding of the Bipolar Disorder is unclear due to the scarcity of causal genes displaying robust effect sizes | Cerebral organoids with dorsal forebrain identity | STEMdiff Cerebral Organoid Kit & maturation kit with BDNF | Cerebral organoids derived from diseased and control iPSCs were not apparently different. Bipolar cerebral organoids show precise defects in response to stimulation and depolarization | [147] |
Bipolar disorder/schizophrenia | Underlying cellular mechanisms for the pathogenesis of Bipolar disorder are not clear due to heterogeneity and technical constraints on cellular complexity of the brain. | Cerebral organoids | SB431542, LDN-193189, Y-27632, Matrigel | Accelerated neuronal differentiation, increased GABAergic specification, decreased cell proliferation following reduced Wnt signaling | [148] |
Developmental and epileptic encephalopathies (DEE) | DEE is a heterogeneous disorder associated with intractable seizures, abnormal brain development, and functional abnormalities. Every patient has distinct genetic background and brain development, which cannot be modeled in a rodent model | Cerebral organoids | bFGF, Y-27632, Matrigel, Insulin, CHIR-99021, vitamin C | Defective DNA damage response, activation of Wnt pathway, abnormal cortical differentiation with disproportionate glutamatergic and GABAergic neurons and increased astrogenesis | [149] |
Timothy syndrome | In vitro modeling of migration of interneurons and their functional integration into human cortex during fetal development remains a challenge | Forebrain spheroids containing cortical (hCS) and subpallium spheroids (hSS) | hCS: dorsomorphin, SB-431542, FGF2, EGF, BDNF, NT-3 hSS: FGF2, EGF, IWP-2, SAG, NT-3, allopregnanolone, retinoic acid, BDNF | Increased saltation frequency led to defective migration of interneurons | [32] |
Tuberous sclerosis complex (TSC) | Highly heterogeneous developmental disorder, cortical tubers are not formed in rodent models | Cortical spheroid | Dorsomorphin, SB431542, EGF, FGF, BDNF, NT-3 | Hypertrophic NPCs, enlarged and dysmorphic neuronal cells with enhanced glia production | [150] |
Angelman syndrome (AS) | AS mice models show synaptic dysfunction and impaired plasticity; however, mechanisms in AS patients remain unclear | Cortical organoids | Dorsomorphin, SB431542, B27 without vitamin A, EGF, FGF-basic, BDNF, GDNF, NT3, db-cAMP | Hyper-excitability and synchronous firing, UBE3A via degradation of calcium- and voltage-dependent big potassium (BK) channels inhibits neuronal hyper-excitability | [151] |
Rett Syndrome | Non-availability of embryonic or perinatal post-mortem tissues from Rett Syndrome patients | Cerebral organoids | Y-27632, SB431542, dorsomorphin, Matrigel, B27 without vitamin A, B27 with vitamin A | increased ventricular area, reduced radial thickness and massive increase of neural progenitor cells followed by abnormal migration of neurons and aberrant neurogenesis | [152] |
Lack of studies on influence of MeCP2 mutation on human interneuron development and function | Human medial ganglionic eminence (MGE) and cortical organoids | LDN-193189, SB-431542, XAV-939, Y-27632, hMGEO: B27 supplement without vitamin A, recombinant SHH, purmorphamine hCO: B27 supplement with vitamin A, BDNF, ascorbic acid, cAMP | BET inhibitor, JQ1, improves the functional deficits of RTT interneurons in brain organoids by showing area-scale synchronization of calcium surges and rescuing the dysregulated transcriptome | [153] | |
RTT phenotypes are widespread and various kind of mutations present the disease phenotypes differently | Dorsal and ventral forebrain organoids | Dorsal Forebrain: Dorsomorphine, A83-01, CHIR99021, SB-431542, Heparin Ventral: SB-431542, LDN-193189, IWP2, SAG and Heparin. BDNF, GDNF, dibutyryl cAMP and ascorbic acid | Premature development of the deep-cortical layer with less proliferating neural progenitor/proliferative cells along with the impairments of interneuron’s migration, dysfunctional RTT neurons, defects in production of medial ganglionic eminence (MGE) progenitors in ventral organoids | [154] | |
Genetic mutation of MeCp2 gene impairs neurodevelopment, still therapeutic treatment for this syndrome is not available | Cortical organoids | SB431542, Dorsomorphin, Y-27632, FGF2, EGF, BDNF, GDNF, NT-3, ascorbic acid and dibutyryl-cAMP | In MECP2‐KO cortical organoids, two lead compounds rescued synaptic pathways and neural network function | [155] | |
Down syndrome | Technically inaccessible pathological samples, presence of asynchronous and heterogeneous disease phenotypes in in vitro culture | Cerebral organoids | N2 supplement, Matrigel | Diminished neurogenesis, reduced proliferation and decreased expression of cortical neuronal markers in layer II and IV in the subcortical regions | [156] |
Vague knowledge of role of Olig genes in GABAergic neuron generation and inconsistencies in recapitulating DS-related genotype–phenotype relationships and contradictory results from human samples | Ventral forebrain organoid | SB431542, Noggin, Matrigel, Laminin, B27-RA, FGF2, hLIF, CHIR99021, Y-27632, SHH, purmorphamine, BDNF, GDNF, dibutyryl-cyclic AMP and ascorbic acid | Overproduction of OLIG2+ Progenitors, disproportionate interneuron production, recognition memory disrupted in neuronal chimeric mice | [157] | |
ASD | Phenotypic heterogeneity and absence of behavioral phenotypes of ASD in rodent models | Telencephalic organoids | B27 supplement without vitamin A, N2 supplement, 2-mercaptoethanol, Y-27632, FGF2, Noggin, rhDkk1, EGF, ascorbic acid, BDNF, GDNF and dibutyryl-cAMP | Elevated neuronal maturation and synaptic overgrowth, Massive inhibitory synapses in ASD-derived neurons, balance between the number of excitatory and inhibitory neurons in ASD-organoids was disturbed | [111] |
Heterogeneous population of neurons expressing forebrain, midbrain, and hindbrain markers was present in monolayer neuronal culture system | Cerebral organoid | DKK-1, BMPRIA-Fc, SB431542, N2 supplement, laminin, and fibronectin, B27 and l-glutamine | Radial glia progenitor cells, GABAergic and glutamatergic neurons were present in cerebral organoids | [114] | |
To integrate the finding that DNA methylation patterns of GAD1 are dysregulated during development from patient’s post-mortem brain and rodent models | Cerebral organoids | Y-27632, Matrigel | Early development follows a diverse methylation patterns in GAD1 in ASD cerebral organoids | [158] | |
Lack of understanding of cell lineages and molecular pathways implicated in telencephalic development in ASD | single neural rosettes derived telencephalic organoids | N2 Supplement, Heparin, B27 Supplement with vitamin A, Dorsomorphin, SB431542, EGF, FGF, BDNF, GDNF and NT-3 | Smaller size of SHANK3-/-organoids, decreased population of neurons with smaller nuclei sizes, decreased number of excitatory synaptic puncta | [159] | |
ASD | Mechanisms underlying valproic acid contribution to accelerating ASD risk in human are not known | Forebrain organoids | SB431542, LDN193189, Y27632, Heparin, CHIR99021, WNT-3A, Matrigel, insulin, Forskolin, Ascorbic Acid, BDNF, GDNF | Disturbed synaptic transmission in VPA treated organoids, differentially expressed genes enriched in calcium, and potassium signaling pathways, oxytocin signaling, synaptic transmission, and neural development | [160] |
How interactions among gene–environment increases ASD risk are unknown | Brain organoids | FGF, EGF, GDNF, BDNF | Exposure of CHD8 +/− organoids with organophosphate pesticide resulted in disturbed Neurite outgrowth and imbalance of excitatory/inhibitory neurotransmitters | [161] | |
Neurodegenerative diseases | |||||
Alzheimer disease | Two-dimensional in vitro models poorly demonstrate the aggregation of extracellular protein involved in Alzheimer disease | Neural organoids | Y-27632, SB431532, IWRe1, Dorsomorphin, heparin Matrigel, B27 supplement | Amyloid beta, tau pathology and endosome abnormality is mimicked in fAD organoids, which were responsive to drug treatment | [162] |
Investigation of AD was hindered in absence of non-invasive method for harvesting brain tissue from living patients | Cerebral organoids | Y27632, Matrigel | Aβ deposits and Tau phosphorylation was observed in cerebral organoids | [163] | |
AD organoids should mimic the genetic background of patients and the functional features of AD brain | Cerebral organoid | Y-27632, Matrigel | AD organoids displayed a small size, increased Aβ42/Aβ40 ratio, disrupted calcium homeostasis, and enhanced neuronal activity | [164] | |
5-Hydroxymethylcytosine contribution to AD pathology has not been determined | Forebrain organoids | FGF, Matrigel, Dorsomorphin, A-83, Heparin CHIR99021,SB-431542, B27, GDNF, BDNF, TFGβ, cAMP | Forebrain organoids mimicked cellular and molecular phenotypes of AD brain. More 5hmC peaks in EBs compared to mature organoids and modulated in intragenic regions | [165] | |
Parkinson | 2D models do not mimic the neuron- glia interaction in a spatially organized cellular architecture | Midbrain-like organoids | SB-431542, LDN-193189, CHIR99021, SAG, Y-27632, ascorbic acid, Matrigel | Midbrain organoids comprised of dopaminergic neurons, which secrete dopamine. In patient organoids, number and complexity of mDANs was decreased | [36] |
Immaturity and heterogeneity of Midbrain organoids (MO) architecture and less efficient protocol | Midbrain organoids | CHIR99021, Noggin, SB431542, Dorsomorphin, A83-01, LDN, FGF8, SAG, Matrigel | MOs comprised of homogenous distribution of dopaminergic neurons, astrocytes and oligodendrocytes | [126] | |
Mutation in DNAJC6 is associated with early-onset Parkinson’s disease, but role of DNAJC6 in PD pathogenesis was unknown | Midbrain-Like organoids (MLOs) | B27, SB431542, Noggin,CHIR99021, Y27632, purmophamine, SHH-C25II, FGF8, BDNF, GDNF, Matrigel, ascorbic acid | MLOs display death of dopamine neuron, aggregation of α-synuclein, dysfunction of mitochondria and lysosomes | [166] | |
Frontotemporal dementia | Role of p25/Cdk5 in tauopathy using organoid model was not known | Cerebral organoids | SB431532, IWRe1,Dorsomorphin, heparin, FBS, matrigel | Tau phosphorylation was reduced and expression of synaptophysin increased in cerebral organoids derived isogenic iPSC lines | [167] |
Zika virus | Inefficient organoid differentiation protocols lead to enormous variability in brain organoids | Cortical organoids and ventral telencephalic organoids | Y-27632, 40% O2, B27 without vitamin A, Growth Factor Reduced Matrigel, heparin, Leukemia Inhibitory Factor | Functional neurons display network-like activities in organoids, Increased progenitor apoptosis leads to smaller organoids size, efficacy of different drug tested | [168] |
Schizophrenia | Functional role of interaction between DISC1 and Ndel1/Nde1 in brain development is difficult to delineate | Forebrain organoids | Dorsomorphine, A83-01, Matrigel, Insulin, WNT-3A, CHIR99021, SB-431542 | Cell-cycle defects in radial glial cells in forebrain organoids resulted in reduced proliferation of neural stem cells in the ventricular zone and disturbed neurogenesis | [169] |
Prenatal hypoxic injury | Technical challenge in accessing human fetal brain tissues and inappropriate animal models have led to poor understanding of effects of hypoxia on progenitor steady state and developmental progression during early human brain development | Cerebral organoids | Matrigel, N2 supplement, B27 supplement without vitamin A, insulin | Immense apoptosis in cerebral organoids followed by greater loss of outer radial glia progenitors and differentiating neuroblasts/immature neurons. During hypoxia, NSCs shifted to symmetric division and replete their population | [170] |
Tuberous sclerosis/periventricular heterotopia | Partial recapitulation of human cortex features by mouse models have led to non-suitability of these models for understanding the mechanisms of neuronal heterotopia | Cerebral spheroids | Y-27632, N2 supplement, Heparin, Matrigel, B27 supplement without vitamin A, Insulin | Defective morphology of neural progenitor cells and altered neuronal migration in a subset of neurons | [171] |
Retinitis pigmentosa | Retinal organoids | Matrigel, G418 and/or Ataluren (PTC124) | Massive cell death of rod photoreceptor at day 150 followed by thinning of the outer nuclear layer by day 180 of culture in patient-derived organoids | [172] | |
Brain cancers | |||||
Brain tumor including glioblastoma and central nervous system primitive neuroectodermal tumor | Modeling of brain tumors is limited owing to genetic heterogeneity and non-suitability of animal models | Neoplastic cerebral organoid | bFGF, Y-27632, Matrigel, vitamin A | By using gene editing techniques and generating gain or loss of function phenotypes for several genes, tumorigenesis was established in cerebral organoids | [173] |
Glioblastoma | Inability to recapitulate the cellular and mutational diversity of parental tumors in in vitro models and longer development time of these models. | Glioblastoma organoids (GBOs) | Patient Glioblastoma Tissue, N2 supplement, B27 supplement w/o vitamin A, insulin | Cellular composition of parental tumors recapitulated in GBOs as they display enormous heterogeneity in cell identity and morphology | [95] |
Limited donor availability for patient-derived xenograft (PDX) models and findings from mouse genetic models are not translatable to human clinical trials | Cerebral organoids | Y-27632, Heparin, N2 supplement, 1X B27 supplement w/o vitamin A, insulin, Matrigel | Invasive phenotype of genetically modified cells inside the organoid caused massive destruction of surrounding organoid structures, and display tumor pathology upon transplantation in mice | [174] | |
Limited GBM models due to the lack of a normal human microenvironment and the inability to recapitulate the GBM biology | Cerebral organoid glioma | Y-27632, Heparin, N2 supplement, 1X B27 supplement w/o vitamin A, insulin, Matrigel | regional proliferation followed by massive invasion accompanied by formation of tumor microtubes and phenocopy patient glioblastoma | [175] | |